Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes. ASCO, Abst:3128, 6/2023.

Document Type

Abstract

Publication Date

6-2023

Keywords

california; sjci

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

Comments

Warnecke B, Nagasaka M, Hallak MNA, Bannoura S, Elliott A, Halmos B, Hoon DSB, Darabi S, Farrell A, Sukari A, Radovich M, Lou E, Sledge G, El-Deiry W, Azmi A, Kim C.

This document is currently not available here.


Share

COinS